Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
Conditions:   IgG4 Related Disease;   IgG4-RD Interventions:   Drug: elotuzumab;   Drug: placebo for elotuzumab;   Drug: methylprednisolone;   Drug: diphenhydramine;   Drug: acetaminophen;   Drug: famotidine;   Drug: prednisone Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Autoimmunity Centers of Excellence;   Bristol-Myers Squibb;   Rho Federal Systems Division, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2021 Category: Research Source Type: clinical trials

A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.
Condition:   Healthy Volunteers Interventions:   Drug: Abrocitinib tablet;   Drug: Abrocitinib Suspension F1;   Drug: Abrocitinib Suspension F2;   Drug: Abrocitinib Suspension F3;   Drug: Abrocitinib Suspension F4;   Drug: Abrocitinib Suspension F5;   Drug: Abrocitinib Suspension F6;   Drug: Famotidine Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2021 Category: Research Source Type: clinical trials